Health

Results: 385-396 of 4709

Cerebral aneurysm treatment device “Nautilus™” (Graphic: Business Wire)

Kaneka Acquires EndoStream Medical Ltd.

DIOSynVax Announces a new Advisory Board as it drives the clinical development of its NextGen Influenza Vaccines including Bird-Flu

PR Newswire associated0

BBI Solutions appoints Alexander A. Socarrás as Chief Executive Officer

PR Newswire associated0

ClearCut Medical Announces Results of a Post Marketing ClearCoast™ Study Presented at the San Antonio Breast Cancer Symposium

ACCESSWIRE logo

Champions Oncology Enhances Clinical Bioanalytical Services Portfolio with New Technology and Additional Leadership

PR Newswire associated0

ScreenPoint Medical Acquires Biomediq A/S to Expand Breast Cancer Risk Assessment Capabilities

Immunovia AB (Publ) presents Nomination Committee

PR Newswire associated0

Hedia and Glooko Partner to Elevate Diabetes Management with Personalised Bolus Insulin Dosing

Business Wire logo

Biomarker and Trial Optimisation Needed to Drive R&D Progress in Alzheimer’s and Related Disorders – ICON Survey

iTeos to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Tiziana Life Sciences Announces Review Article Published in Nature Highlighting Foralumab's Potential in the Treatment of Neurological Disease

In a landmark step towards advancing cancer care in the Middle East, BOSTON ONCOLOGY ARABIA and SPIMACO have signed a Memorandum of Understanding (MoU) to localize the production of advanced oral oncology treatments in the Kingdom of Saudi Arabia. (Photo: Business Wire)

BOSTON ONCOLOGY ARABIA and SPIMACO Partner to Localize Advanced Oral Oncology Treatments in Saudi Arabia